Trademark: CAREDX 2189137
Word
CAREDX
ID
2189137
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
09 April 2021
Registration Date
09 April 2021
Renewal Date
09 April 2031
Owner(s)
Service
Goods and Services:
Class 5:
Biological chemical test kits for medical laboratory use, in analysis of gene expression, and organ transplant rejection or tolerance.
Biological chemical test kits for medical laboratory use, in analysis of gene expression, and organ transplant rejection or tolerance.
Class 9:
Downloadable computer application software for mobile devices, namely, software for monitoring and management of patient healthcare information and data.
Downloadable computer application software for mobile devices, namely, software for monitoring and management of patient healthcare information and data.
Class 42:
Providing online non-downloadable software for monitoring and managing patient healthcare information and data; software as a service (SAAS) services featuring software that monitors and manages patient healthcare information and data; medical laboratory services.
Providing online non-downloadable software for monitoring and managing patient healthcare information and data; software as a service (SAAS) services featuring software that monitors and manages patient healthcare information and data; medical laboratory services.
Class 44:
Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and organ transplant rejection or tolerance.
Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and organ transplant rejection or tolerance.